Hep C BC Legacy – Page 96 – Hep C BC Legacy

Hep C BC Legacy

Hep C BC Legacy

Blog Archive

How Gilead’s New Hepatitis C Virus Combination Stacks Up to the Competition

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
July 5, 2016

Blog Archive

U.S.: Medicaid, Private Insurers Begin To Lift Curbs On Pricey Hepatitis C Drugs

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
July 5, 2016

Blog Archive

Fibrosis in HCV genotype 3 progresses with age

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
July 3, 2016

Blog Archive

U.S.: MassHealth to pay for hepatitis C drugs for all infected members

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
June 30, 2016

Blog Archive

Bayer’s Regorafenib Significantly Improves Overall Survival in Patients with Unresectable Liver Cancer

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
June 29, 2016

Blog Archive

A Comprehensive And Fair Solution To The Price Of Medicines

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
June 28, 2016

Blog Archive

U.S. Food and Drug Administration Approves Gilead’s Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
June 28, 2016

Blog Archive

Unrestricted Medicaid Access to Novel Hepatitis C Therapies May Reduce Overall Costs

This page is an archive. Its content may no longer be accurate and was last updated on the original publication date. It is intended for reference and as a historical record only. For hep C questions, call Help4Hep BC at…

Hep C BC Legacy
June 27, 2016